Reading and Resources

Mayo Clinic. Idiopathic Hypersomnia. https://www.mayoclinic.org/diseases-conditions/hypersomnia/symptoms-causes/syc-20362332.
Hypersomnia Foundation. Idiopathic Hypersomnia. https://www.hypersomniafoundation.org/ih/
Icahn School of Medicine at Mount Sinai. Idiopathic Hypersomnia. https://www.mountsinai.org/health-library/diseases-conditions/idiopathic-hypersomnia.
Sleep Foundation. Idiopathic Hypersomnia. Updated December 22, 2023. https://www.sleepfoundation.org/hypersomnia/idiopathic-hypersomnia.

Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain. 1997;120:1423-1435. doi:10.1093/brain/120.8.1423
Billiard M, Merle C, Carlander B, Ondze B, Alvarez D, Besset A.. Idiopathic hypersomnia. Psychiatr Clin Neurosci. 1998;52:125-129. doi:10.1111/j.1440-1819.1998.tb00987.x
Bock J, Covassin N, Somers V. Excessive daytime sleepiness: An emerging marker of cardiovascular risk. Heart. 2022;108:1761-1766. doi:10.1136/heartjnl-2021-319596
Heo YA. Calcium, Magnesium, potassium and sodium oxybates (Xywav^®)in sleep disorders: A profile of its use. CNS Drugs. 2022;36:541-549. doi:10.1007/s40263-022-00912-6
Morse AM, Dauvilliers Y, Arnulf I, et al. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia. J Clin Sleep Med. 2023;19:1811-1822. doi:10.5664/jcsm.10698
Pascoe M, Bena J, Foldvary-Schaefer N. Effects of pharmacotherapy treatment on patient-reported outcomes in a narcolepsy and idiopathic hypersomnia cohort. J Clin Sleep Med. 2019;15:1799-1806. doi:10.5664/jcsm.8088
Thorpy MJ, Krahn L, Ruoff C, Foldvary-Schaefer N. Clinical considerations in the treatment of idiopathic hypersomnia. Sleep Med. 2024;119:488-498. doi:10.1016/j.sleep.2024.05.013
Trotti LM. Idiopathic hypersomnia. Sleep Med Clin. 2017;12:331-344. doi:10.1016/j.jsmc.2017.03.009

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers